# PHASE 13 — PRODUCTION ASSET GENERATION REPORT

**Target Story ID:** `anthropic-claude-crispr-art-enzyme-2026`  
**Story Title:** Anthropic's Claude Autonomously Discovers Novel CRISPR-Like Enzyme System in Viruses  
**Production Phase:** Phase 13 — Production Asset Generation  
**Execution Timestamp:** 2026-09-26T19:30:00+07:00  
**Engine:** Native Procedural Vector Engine + macOS `sips` (Apple CoreGraphics 1080x1920 RGBA)  
**Status:** `PHASE_13_ASSETS_READY_FOR_QA`  

---

## 1. Executive Summary

All 6 production visual assets for Short #2 (`anthropic-claude-crispr-art-enzyme-2026`) have been generated as scalable vector master files (SVG) and rasterized into high-resolution 1080x1920 (9:16 portrait) PNG production images. Every asset strictly adheres to:
- **`BIOLOGICAL_MASTER_DESIGN_ART_v1`** (bacteriophage icosahedral capsid, cyan Reverse Transcriptase, violet partner gene, mint-green tandem repeat arrays, amber-gold short RNA).
- **AI News Factory Visual Style Bible v1.0** (dark canvas `#070A0F`, clean typography, mobile safe zones).
- **Phase 12R Remediation Requirements**:
  - `AST-04-WETLAB-GEL-EVIDENCE`: 100% original procedural scientific simulation (`ORIGINAL_SCIENTIFIC_SIMULATION`, `RECONSTRUCTED`, `ORIGINAL_VECTOR_DIAGRAM`) with explicit conceptual disclosure (`"ORIGINAL SCIENTIFIC SIMULATION — NOT ORIGINAL EXPERIMENTAL DATA"`).
  - Shot 05 text limit compliance: Primary card `"NOT GENE THERAPY • NEW BIOLOGY"` (5 words) and secondary badge `"FUNDAMENTAL BIOLOGY • NO GENE EDITING"` (5 words, $\le 6$).
  - Negative boundary guardrail: Absolutely no human gene editing, clinical therapy, or medical claims.

---

## 2. Shot-by-Shot Production Asset Inventory

| Shot | Asset ID | Master SVG File | Raster PNG File | Format / Resolution | Visual Truth Mode | Rights Status | File Size | QC Status |
| :---: | :--- | :--- | :--- | :---: | :---: | :---: | :---: | :---: |
| **01** | `AST-01-PHAGE-LANDING` | `data/visuals/production_assets_art/shot-01.svg` | `data/rendered/anthropic-claude-crispr-art-enzyme-2026/assets/generated/shot-01.png` | SVG / PNG<br>1080x1920 | `CONCEPTUAL` | `ORIGINAL_AI_SYNTHESIZED` | 1,213,282 B | **PASS** |
| **02** | `AST-02-AGENT-CLUSTER-MATRIX` | `data/visuals/production_assets_art/shot-02.svg` | `data/rendered/anthropic-claude-crispr-art-enzyme-2026/assets/generated/shot-02.png` | SVG / PNG<br>1080x1920 | `DIAGRAM` | `ORIGINAL_VECTOR_DIAGRAM` | 1,196,188 B | **PASS** |
| **03** | `AST-03-ART-MOLECULAR-BLUEPRINT` | `data/visuals/production_assets_art/shot-03.svg` | `data/rendered/anthropic-claude-crispr-art-enzyme-2026/assets/generated/shot-03.png` | SVG / PNG<br>1080x1920 | `DIAGRAM` | `ORIGINAL_VECTOR_DIAGRAM` | 1,046,405 B | **PASS** |
| **04** | `AST-04-WETLAB-GEL-EVIDENCE` | `data/visuals/production_assets_art/shot-04.svg` | `data/rendered/anthropic-claude-crispr-art-enzyme-2026/assets/generated/shot-04.png` | SVG / PNG<br>1080x1920 | `RECONSTRUCTED` | `ORIGINAL_SCIENTIFIC_SIMULATION` | 1,002,532 B | **PASS** |
| **05** | `AST-05-BOUNDARY-LATTICE` | `data/visuals/production_assets_art/shot-05.svg` | `data/rendered/anthropic-claude-crispr-art-enzyme-2026/assets/generated/shot-05.png` | SVG / PNG<br>1080x1920 | `DIAGRAM` | `ORIGINAL_VECTOR_DIAGRAM` | 902,606 B | **PASS** |
| **06** | `AST-06-BRAND-CTA-LOCKUP` | `data/visuals/production_assets_art/shot-06.svg` | `data/rendered/anthropic-claude-crispr-art-enzyme-2026/assets/generated/shot-06.png` | SVG / PNG<br>1080x1920 | `DIAGRAM` | `PROPRIETARY_BRAND_ASSET` | 893,054 B | **PASS** |

---

## 3. Comprehensive Quality Control Audit

| Audit Dimension | Standard / Specification | Observed Result | Status |
| :--- | :--- | :--- | :---: |
| **Total Assets Generated** | Exactly 6 shot assets | 6 Master SVGs + 12 Raster PNGs | **PASS** |
| **Missing Assets** | 0 allowed | 0 missing | **PASS** |
| **Resolution & Aspect Ratio** | 1080x1920 portrait (9:16) | Exactly 1080x1920 across all 6 PNGs | **PASS** |
| **Rights Blockers** | 0 third-party / 0 unresolved rights | 0 third-party assets (100% original / proprietary) | **PASS** |
| **AST-04 Guardrail** | `ORIGINAL_SCIENTIFIC_SIMULATION` / `RECONSTRUCTED` | Preserved with explicit conceptual disclosure | **PASS** |
| **Scientific Boundary** | No human gene editing / no clinical therapy | Strict boundary badge + refutation shield | **PASS** |
| **Visible-Text Word Count** | Maximum 6 words per text card | All cards 3–5 words ($\le 6$) | **PASS** |
| **JSON Schema Validation** | `src/validate_artifacts.py` | 16/16 artifacts PASSED deep validation | **PASS** |
| **Render Engine Tests** | `pytest tests/` | 13/13 unit tests PASSED | **PASS** |
| **Storyboard-to-Asset Mapping** | 1:1 mapping with fact IDs and timecodes | 6/6 shots fully mapped | **PASS** |

---

## 4. Overall Asset QA Verdict

- **TOTAL ASSETS:** 6
- **MISSING ASSETS:** 0
- **RIGHTS BLOCKERS:** 0
- **SCIENTIFIC BLOCKERS:** 0
- **TEXT LIMIT VIOLATIONS:** 0
- **SCHEMA TEST RESULT:** PASS (16/16)
- **PYTEST RESULT:** PASS (13/13)
- **OVERALL ASSET QA STATUS:** `PHASE_13_ASSETS_READY_FOR_QA`

---

## Mandatory Hard Stop
Assets are generated and cataloged on disk. The pipeline is stopped.  
Zero audio synthesized, zero video rendered, zero YouTube actions taken.
